Invesco Ltd. X Biotech Inc. Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $214,539 - $290,771	-24,831 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.95 - $16.07 $32,379 - $47,518	-2,957 Reduced 10.64%	24,831 $277,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $16,640 - $23,438	1,285 Added 4.85%	27,788 $359,000
Q2 2021 Aug 17, 2021	BUY	$15.83 - $17.84 $30,013 - $33,824	1,896 Added 7.71%	26,503 $439,000
Q1 2021 May 17, 2021	BUY	$15.92 - $20.3 $223,007 - $284,362	14,008 Added 132.16%	24,607 $422,000
Q4 2020 Feb 16, 2021	BUY	$15.65 - $19.92 $165,874 - $211,132	10,599 New	10,599 $166,000
Q3 2020 Nov 16, 2020	SELL	$13.97 - $21.16 $152,887 - $231,575	-10,944 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $113,708 - $175,870	10,944 New	10,944 $151,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $118M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.